RENT.COM.AU LIMITED — Board/Management Information 2012

May 17, 2012

==> picture [181 x 65] intentionally omitted <==

ABN 25 062 063 692
945 Wellington Street
West Perth  WA  60095
Telephone +618 9322 7600
Facsimile +618 9322 7602
www.selectvaccines.com.au

18 May 2012

Manager of Company Announcements ASX Limited Level 6, 20 Bridge Street Sydney NSW 2000

By E‐Lodgement

SELECT VACCINES LIMITED

Appointment of Managing Director Elect

The Directors’ of Select Vaccines Limited (“Select” or “the Company”) (to be renamed Select Exploration Limited) are pleased to announce the appointment of Mr Shane Cranswick as the Managing Director Elect of the Company.

As announced on 19 March 2012, Select has signed a Share Sale Agreement to acquire (subject to shareholder approval) more than 4,000 square km of tenements in Tanzania which it considers prospective for coal and uranium. The projects potentially contain units of the Karoo Sedimentary Sequence which is a geological structure that hosts major known deposits in Africa, including significant coking coal deposits in neighbouring Mozambique and significant coal and uranium deposits in Tanzania. The licenses have never been drilled, and Select intends to commence a 10,000m drilling program early in the final quarter of 2012.

Mr Cranswick’s appointment is subject to shareholder approval of the Tanzanian transaction outlined above and the successful re‐compliance of Select with ASX listing rules. The Company is expecting to release a Notice of Meeting shortly to approve the transaction.

On Mr Cranswick’s appointment, Chairman Ian Macliver said “we are very excited to welcome a person of Shane’s caliber and experience as Managing Director Elect. Shane’s corporate expertise combined with his extensive project development experience will be a key asset for the Company in progressing Select’s proposed coal and uranium projects in Tanzania.”

On his appointment Mr Cranswick said “I am pleased to be joining a company with a tenement portfolio in a progressive and resource focused country such as Tanzania. I am also delighted to be working with a board that has had proven experience in coal and exploration projects in Africa. Once shareholder approval is received I am looking forward to implementing a thorough exploration program to further progress the value in the Company’s projects.”

Mr Cranswick is an accomplished mining executive with over 10 years’ experience in senior management roles in resources companies both in Australia and overseas with a focus on coal, uranium and iron ore.

As Chief Financial Officer of Berkley Resources Ltd (ASX: BKY), Mr Cranswick played an integral role in the development of the company’s flagship uranium projects in Spain. Mr Cranswick has also previously worked as Chief Financial Officer of ASX listed Indo Mines Ltd (ASX: IDO) focusing on the company’s coal production and iron assets in Indonesia.

Mr Cranswick was also a founding director of Mantra Resources Ltd which had significant success in the exploration and development of uranium projects in Tanzania. Most recently, Mr Cranswick held a senior commercial role with Rio Tinto focusing on the development of the large scale Simandou Iron Ore Project in Guinea, Africa.

Mr Cranswick gained a Bachelor of Commerce degree from the University of Western Australia and commenced his career with an international Chartered Accounting firm before spending approximately 8 years with Apollo Group Pty Ltd, a corporate services provider to listed entities, focusing on the acquisition of resources projects and implementation of management teams to oversee the development of the projects. Mr Cranswick is a member of the Institute of Chartered Accountants in Australia, the Financial Services Institute of Australasia and the Institute of Chartered Secretaries.

A summary of the key terms of employment for Mr Cranswick is set out in Annexure A. As part of the re‐compliance process the Company is proposing a share consolidation on the basis that every one hundred (100) shares currently on issue is consolidated into one (1) share. The proposed share consolidation is subject to shareholder approval. Mr Cranswick’s employment package detailed in Annexure A is provided on a post consolidation basis.

The Board is pleased to announce Mr Cranswick’s appointment, looks forward to progressing the Tanzanian transaction and working with Mr Cranswick to accelerate the Company’s exploration activities.

For and on behalf of the board

==> picture [166 x 44] intentionally omitted <==

IAN MACLIVER Chairman

ANNEXURE A

This document provides a summary only of the key provisions Mr Cranswick’s employment agreement on a post consolidation basis.

SUMMARY OF TERMS OF EMPLOYMENT AGREEMENT FOR SHANE CRANSWICK

1. Appointment

Subject to shareholder approval and successful re‐compliance with the ASX listing rules, Mr Cranswick will join the company as Managing Director.

2. Term

The Employment will be subject to a three (3) month probationary period, during which time either party may cease employment if it is deemed that the working relationship is not satisfactory. The Company can waive the probationary period at its discretion. Following the probationary period, the appointment is ongoing subject to the Termination provisions.

3. Remuneration

a) Annual Fixed Salary Package: $225,000 per annum (inclusive of statutory superannuation), reviewed annually.

• b) Performance Rights: Subject to shareholder approval of the Company’s performance rights plan which will be issued with the Notice of Meeting for the transaction, Mr Cranswick will be entitled to the following Performance Rights (on a post consolidation basis):

Number of Performance Rights	Performance Condition	Milestone Date
100,000	Continuous employment with the Company	1 July 2013
100,000	Continuous employment with the Company	1 July 2014
100,000	Continuous employment with the Company and subject to a Market Price Test. The Market Price Test measures the increase in share price of the Company such that the performance rights will vest if the 10 day VWAP of trading in the Company’s shares at any time from the Commencement Date up to the 1 July 2013 milestone date is not less than 50% above the price at which the capital raising is undertaken aspart of the Company’s re‐compliance.	On or before 1 July 2013
100,000	Continuous employment with the Company and subject to a Market Price Test. The Market Price Test measures the increase in share price of the Company such that the performance rights will vest if the 10 day VWAP of trading in the Company’s shares at any time from the Commencement Date up to the 1 July 2014 milestone date is not less than 85% above the price at which the capital raising is undertaken aspart of the Company’s re‐compliance.	On or before 1 July 2014
200,000	Achievement of key performance indicators as agreed by the Board in relation to: • Meeting exploration timetables • Meeting exploration budgets • Maintenance of tenements to the board’s satisfaction	1 July 2013

4. Termination

The Company may at its sole discretion terminate the Employment of the Managing Director by giving not less than one (1) month’s written notice.

The Managing Director must provide one (1) months written notice to the Company.